Inventor · disambiguated record
Nikolay Nifantiev
Also filed as: NIFANTIEV NIKOLAY · NIFANTIEV NIKOLAY E · NIFANTIEV NIKOLAY EDUARDOVICH
12 granted patents·12 pending applications·69 citations·filing 2001–2021
89Inventor score
Files withCERAMOPTEC IND INC11BRIGHAM & WOMENS HOSPITAL INC5NIFANTIEV NIKOLAY2FARMER GERARD1GRÄFE SUSANNA1
Top patents by PatentIndex Score
24 records- 0188US10034927B2Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharidesBRIGHAM & WOMENS HOSPITAL INC·Filed 2016·Granted Jul 31, 2018·7 cites·17 claims
- 0288US8492364B2Methods and compositions relating to synthetic β-1,6 glucosamine oligosaccharidesPIER GERALD B·Filed 2009·Granted Jul 23, 2013·11 cites·10 claims
- 0386US6777402B2Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufactureCERAMOPTEC IND INC·Filed 2002·Granted Aug 17, 2004·21 cites·31 claims
- 0485US9474806B2Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharidesBRIGHAM & WOMENS HOSPITAL INC·Filed 2013·Granted Oct 25, 2016·7 cites·37 claims
- 0583US8815931B2Oral formulations for tetrapyrrole derivativesGRÄFE SUSANNA·Filed 2010·Granted Aug 26, 2014·18 cites·5 claims
- 0681US11123416B2Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharidesBRIGHAM & WOMENS HOSPITAL INC·Filed 2018·Granted Sep 21, 2021·1 cites·6 claims
- 0777US2022175904A1Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharidesBRIGHAM & WOMENS HOSPITAL INC·Filed 2021·Application pending·0 cites
- 0865US6949581B2Water-soluble mono-PEGylated tetrapyrrole derivatives for photodynamic therapy and method of productionCERAMOPTEC IND INC·Filed 2003·Granted Sep 27, 2005·4 cites·7 claims
- 0962US2009030257A1Anti-microbial photodynamic therapyCERAMOPTEC IND INC·Filed 2007·Application pending·0 cites
- 1060US9216166B2Anti-microbial photodynamic therapyNIFANTIEV NIKOLAY E·Filed 2007·Granted Dec 22, 2015·0 cites·7 claims
- 1155US2008214460A1Formulations for cosmetic and wound care treatments with photosensitizers as fluorescent markersCERAMOPTEC IND INC·Filed 2008·Application pending·0 cites
- 1255US2008274169A1Photosensitizer formulations for topical applicationsCERAMOPTEC IND INC·Filed 2007·Application pending·0 cites
- 1354US2009162423A1Formulations for cosmetic and wound care treatments with photosensitizes as fluorescent markersCERAMOPTEC IND INC·Filed 2007·Application pending·0 cites
- 1454US2009081281A1Photosensitizer Formulation for Topical ApplicationsFARMER GERARD·Filed 2007·Application pending·0 cites
- 1553US8580839B2Photosensitizer formulations and their useNIFANTIEV NIKOLAY·Filed 2008·Granted Nov 12, 2013·0 cites·8 claims
- 1653US7825153B2Photosensitizer formulations and their useCERAMOPTEC IND INC·Filed 2005·Granted Nov 2, 2010·0 cites·6 claims
- 1748US2003176326A1Photosensitzers for photodynamic therapy of microbial infectionsCERAMOPTEC IND INC·Filed 2002·Application pending·0 cites
- 1847US2010286255A1Method for extracting secoisolariciresinol and dihydroquercetin from woodNIFANTIEV NIKOLAY EDUARDOVICH·Filed 2008·Application pending·0 cites
- 1944US2003004334A1Water-soluble porphyrin derivatives and methods of their preparationCERAMOPTEC IND INC·Filed 2001·Application pending·0 cites
- 2042US10927101B2Neopetrosides A and B, and synthesis method thereofUNIV INJE IND ACAD COOP FOUND·Filed 2017·Granted Feb 23, 2021·0 cites·4 claims
- 2142US2011021973A1Formulations for cosmetic and wound care treatments with photosensitizers as fluorescent markersCERAMOPTEC IND INC·Filed 2010·Application pending·0 cites
- 2241US2003088092A1Water-soluble porphyrin derivatives and methods of their preparationCERAMOPTEC IND INC·Filed 2002·Application pending·0 cites
- 2338US12428417B2Inhibitors of macrophage migration inhibitory factorBRIGHAM & WOMENS HOSPITAL INC·Filed 2020·Granted Sep 30, 2025·0 cites·16 claims
- 2426US2011245198A1Enhanced treatments to kill or debilitate pathogenic microorganisms of a mammalian bodyNIFANTIEV NIKOLAY·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →